SAS and Posit join forces on governed AI for life sciences

SAS and Posit have partnered to help life science organizations combine SAS and open source technologies, initially focusing on clinical development. The integration is designed to give teams more flexibility across SAS, R, Python and SQL while maintaining governance for regulated research.
- SAS and Posit are partnering on governed AI for life sciences.
- The initial focus is clinical development and regulatory requirements.
- SAS Viya and SAS Clinical Acceleration will integrate with Posit tools.
- The collaboration supports workflows across SAS, R, Python and SQL.
- Posit and SAS are working with customers on future clinical workflows.
Integration targets clinical development
The partnership will connect SAS Viya and SAS Clinical Acceleration with Posit Workbench, Positron, Posit Connect and Posit Package Manager. According to SAS and Posit, the combined offering will allow customers to work with SAS and R more seamlessly while supporting regulatory requirements.
SAS Clinical Acceleration is built on SAS Viya, SAS' data and AI platform. It combines a secure clinical data repository, a statistical computing environment and AI-assisted clinical data transformations intended to prepare clinical research for regulatory submission.
Posit's technologies will extend those capabilities by giving users a managed enterprise environment for incorporating open source technology. The companies said the arrangement is intended to bring the flexibility of open source tools together with the controls required in regulated clinical research.
SAS and open source tools in one workflow
Under the collaboration, customers can use managed, versioned R environments while maintaining control of dependencies and interoperability constraints with SAS Clinical Acceleration. Posit tools work directly with SAS Viya, creating a connected environment for data scientists and developers working across SAS, R, Python and SQL.
Teams can use Positron and Posit Assistant to develop code, while Posit Package Manager helps keep R and Python environments consistent and reproducible. Eric Pite, Posit's Senior Vice President of Product and Strategy, said in the announcement that a programmer can write SAS and R code in Positron, with SAS Viya running the SAS code under that programmer's own permissions.
Mark Lambrecht, Global Head of Health Care and Life Sciences Solutions at SAS, said, "Life sciences organizations can now bring together the flexibility of open source with the rigor required for regulated clinical research." He added that the partnership would give customers more freedom while preserving transparency and governance.
What the partnership means for clinical teams
The companies frame the integration as a way to reduce the need for separate workflows when programmers use SAS alongside open source languages. Dilip Raghunathan, Business Solutions Partner at Regeneron, said the previous approach could involve workarounds, copied data and duplicate access-control governance. He said Regeneron programmers can now write both languages in one session under their own access rights, with AI assistance operating within those controls.
Posit and SAS said they are working with joint customers to decide which clinical workflows to support next. The initial focus on clinical development places the partnership within a setting where reproducibility, permissions, transparency and regulatory preparation are central requirements. The companies' stated aim is to offer more tool choice without removing the governance features life science organizations rely on.
SAS and Posit experts are scheduled to attend PHUSE EU Connect in Glasgow from Nov. 15, 18. Posit will be at booth 43 and SAS at booth P3.
PR Newswire: SAS and Posit partner for governed AI in life sciences
PR Newswire: SAS and Posit partner for governed AI in life sciences


